Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 29;11(11):ofae635.
doi: 10.1093/ofid/ofae635. eCollection 2024 Nov.

A Bundle of the "Top 10" Outpatient Parenteral Antimicrobial Therapy Publications in 2023

Lindsey M Childs-Kean  1 , Alison M Beieler  2 , Nicolás Cortés-Penfield  3 , Sara C Keller  4   5 , Christina G Rivera  6 , Keenan L Ryan  7 , Leah H Yoke  8   9 , Monica V Mahoney  10
Affiliations
Review

A Bundle of the "Top 10" Outpatient Parenteral Antimicrobial Therapy Publications in 2023

Lindsey M Childs-Kean et al. Open Forum Infect Dis. .

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) has become more common in infectious diseases practice settings. Similarly, OPAT-related publications have also increased. The objective of this article was to summarize clinically important OPAT-related publications from 2023. Eighty-one articles were found on initial search, with 52 meeting inclusion criteria. A survey containing the 19 articles that had at least 1 citation was sent to an email listserv of multidisciplinary clinicians with OPAT experience. This article summarizes the "top 10" 2023 OPAT articles from the survey results.

Keywords: COpAT; OPAT; monitoring parameters; outpatient parenteral antimicrobial therapy; readmission factors.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. L. M. C.-K. has received honoraria from the American Society of Health-System Pharmacists and the American Association of Colleges of Pharmacy. A. M. B. is co-chair of the Infectious Diseases Society of America (IDSA) Advanced Practice Provider interest group. S. C. K. has received honoraria from McGraw Hill Educational; grant support from the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, and the Department of Veterans Affairs. M. V. M. has received research funding from Merck and has been a consultant to BD Biosciences, Cidara Therapeutics, GSK, and Pfizer. C. G. R. has received research funding and consulting fees from Gilead Sciences; honoraria from Jobson Health, Continuing Education Network, Ce Impact, Insmed, and Gilead Sciences; and travel/lodging support from Ce Impact. K. L. R. has received honoraria from PharmCon. L. H. Y. has received honoraria from Washington Academy of Physician Assistants, Journal of the Advanced Practitioner in Oncology, and American Society for Transplantation and Cellular Therapy; has received payment for expert testimony from McNabola Law Group; is a board member of the Washington Academy of Physician Assistants; and is co-chair of the IDSA Advanced Practice Provider interest group. N. C.-P. reports no potential conflicts.

Figures

Figure 1.
Figure 1.
Selection of articles. Abbreviations: COpAT, complex outpatient antimicrobial therapy; GOAT, Grading Outcomes–based research in Antimicrobial Therapy; OPAT, outpatient parenteral antimicrobial therapy.
See this image and copyright information in PMC

References

    1. Norris AH, Shrestha NK, Allison GM, et al. 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis 2019; 68:e1–35. - PubMed
    1. Seaton RA, Ritchie ND, Robb F, Stewart L, White B, Vallance C. From ‘OPAT’ to ‘COpAT’: implications of the OVIVA study for ambulatory management of bone and joint infection. J Antimicrob Chemother 2019; 74:2119–21. - PubMed
    1. Rivera CG, Beieler AM, Childs-Kean LM, et al. A bundle of the top 10 OPAT publications in 2021. Open Forum Infect Dis 2022; 9:ofac242. - PMC - PubMed
    1. Childs-Kean LM, Beieler AM, Coroniti AM, et al. A bundle of the top 10 OPAT publications in 2022. Open Forum Infect Dis 2023; 10:ofad283. - PMC - PubMed
    1. Agnihotri G, Gross AE, Seok M, et al. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program. Antimicrob Steward Healthc Epidemiol 2023; 3:e33. - PMC - PubMed